BRAG Q1 2026 Earnings EPS Surpasses Estimates Amid Prudent Cost Controls QVCGA Q3 2025 Earnings Deep Loss Reported as Revenue Remains Undisclosed Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development RILYL Q1 2024 Earnings Net Loss Reported Preferred Stock Price Edges Higher CCSI Q1 2026 Earnings Strong EPS Beat Amidst Cautious Outlook GD Q1 2026 Earnings Strong EPS Beat Amidst Operational Execution